4.7 Review

The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia

Journal

ANTIOXIDANTS
Volume 9, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/antiox9090779

Keywords

oxidative stress; BACH1; Nrf2; Down syndrome; Alzheimer disease

Funding

  1. NIH [AG-055596-01A1]

Ask authors/readers for more resources

Down syndrome (DS) is the most common genetic cause of intellectual disability that is associated with an increased risk to develop early-onset Alzheimer-like dementia (AD). The brain neuropathological features include alteration of redox homeostasis, mitochondrial deficits, inflammation, accumulation of both amyloid beta-peptide oligomers and senile plaques, as well as aggregated hyperphosphorylated tau protein-containing neurofibrillary tangles, among others. It is worth mentioning that some of the triplicated genes encoded are likely to cause increased oxidative stress (OS) conditions that are also associated with reduced cellular responses. Published studies from our laboratories propose that increased oxidative damage occurs early in life in DS population and contributes to age-dependent neurodegeneration. This is the result of damaged, oxidized proteins that belong to degradative systems, antioxidant defense system, neuronal trafficking. and energy metabolism. This review focuses on a key element that regulates redox homeostasis, the transcription factor Nrf2, which is negatively regulated by BACH1, encoded on chromosome 21. The role of the Nrf2/BACH1 axis in DS is under investigation, and the effects of triplicated BACH1 on the transcriptional regulation of Nrf2 are still unknown. In this review, we discuss the physiological relevance of BACH1/Nrf2 signaling in the brain and how the dysfunction of this system affects the redox homeostasis in DS neurons and how this axis may contribute to the transition of DS into DS with AD neuropathology and dementia. Further, some of the evidence collected in AD regarding the potential contribution of BACH1 to neurodegeneration in DS are also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles

Marzia Perluigi, Anna Picca, Elita Montanari, Riccardo Calvani, Federico Marini, Roberto Matassa, Antonella Tramutola, Alberto Villani, Giuseppe Familiari, Fabio Di Domenico, D. Allan Butterfield, Kenneth J. Oh, Emanuele Marzetti, Diletta Valentini, Eugenio Barone

Summary: The study found that nEVs isolated from DS children showed a significant increase in insulin resistance marker pIRS1(Ser636) and hyperactivation of the Akt/mTOR/p70S6K pathway downstream from IRS1, possibly driven by higher inhibition of PTEN. Additionally, high levels of pGSK3 beta(Ser9) were also observed. These alterations in the insulin-signaling/mTOR pathways are believed to be early events in the DS brain, contributing to the cognitive dysfunction and intellectual disability seen in this unique population.

ALZHEIMERS & DEMENTIA (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Interplay Among Oxidative Stress, Brain Insulin Resistance and AMPK Dysfunction Contribute to Neurodegeneration in Type 2 Diabetes and Alzheimer Disease

D. Allan Butterfield, Eugenio Barone, Fabio Di Domenico, Marzia Perluigi

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Editorial Material Cell Biology

Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome

Eugenio Barone

NEURAL REGENERATION RESEARCH (2022)

Article Biochemistry & Molecular Biology

CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome

Sara Pagnotta, Antonella Tramutola, Eugenio Barone, Fabio Di Domenico, Valeria Pittala, Loredana Salerno, Valentina Folgiero, Matteo Caforio, Franco Locatelli, Stefania Petrini, D. Allan Butterfield, Marzia Perluigi

Summary: This study focuses on the role of BACH1/NRF2 ratio in the regulation of antioxidant response and its impact on patients with Down syndrome. The results show that overexpression of BACH1 disrupts the induction of antioxidant response genes, leading to oxidative damage accumulation. Additionally, administration of CAPE and VP961 promotes NRF2 nuclear translocation in cells from Down syndrome patients, improving antioxidant response.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Review Biochemistry & Molecular Biology

Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update

Flavia Agata Cimini, Marzia Perluigi, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone

Summary: The review highlights the significance of the insulin signaling pathway and the regulatory role of biliverdin reductase-A in insulin signaling, as well as its impact on cell dysfunctions in metabolic and neurodegenerative disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

News Item Clinical Neurology

Aberrant protein networks in Alzheimer disease

Marzia Perluigi, Eugenio Barone

Summary: The use of proteomics approach reveals that changes in protein expression associated with Alzheimer's disease may not always be reflected in changes in RNA levels, emphasizing the importance of directly studying proteomic changes to fully understand the pathogenesis of Alzheimer's disease.

NATURE REVIEWS NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling

Chirag Vasavda, Evan R. Semenza, Jason Liew, Ruchita Kothari, Ryan S. Dhindsa, Shruthi Shanmukha, Anthony Lin, Robert Tokhunts, Cristina Ricco, Adele M. Snowman, Lauren Albacarys, Francesco Pastore, Cristian Ripoli, Claudio Grassi, Eugenio Barone, Michael D. Kornberg, Xinzhong Dong, Bindu D. Paul, Solomon H. Snyder

Summary: Synapses play a crucial role in connecting neurons and transmitting information. This study investigates the role of the enzyme biliverdin reductase (BVR) in synaptic function and plasticity. The findings suggest that BVR acts as a bridge between key signaling molecules in synaptic adhesion pathways, and its absence leads to deficits in learning and memory.

SCIENCE SIGNALING (2022)

Article Biochemistry & Molecular Biology

A Bioengineering Strategy to Control ADAM10 Activity in Living Cells

Francesco Pastore, Martina Battistoni, Raimondo Sollazzo, Pietro Renna, Fabiola Paciello, Domenica Donatella Li Puma, Eugenio Barone, Onur Dagliyan, Cristian Ripoli, Claudio Grassi

Summary: ADAM10 is a cell surface protease involved in the cleavage of membrane proteins. Dysregulation of ADAM10 has been linked to various pathological conditions, including AD. Researchers have designed a bioengineering strategy to control the cleavage activity of ADAM10, providing insights into AD treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down Syndrome

Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, Sara Pagnotta, Gabriele Ruffolo, Pierangelo Cifelli, Federico Marini, Cristian Ripoli, Eleonora Palma, Claudio Grassi, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

Summary: Down syndrome (DS) is associated with Alzheimer's disease (AD) and brain insulin resistance. The KYCCSRK peptide has shown potential for improving insulin signaling in DS and reducing AD-like neuropathology in mice.

ANTIOXIDANTS (2023)

Article Biochemistry & Molecular Biology

Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans

Flavia Agata Cimini, Antonella Tramutola, Ilaria Barchetta, Valentina Ceccarelli, Elena Gangitano, Simona Lanzillotta, Chiara Lanzillotta, Maria Gisella Cavallo, Eugenio Barone

Summary: BVRA protein levels can change dynamically in response to insulin and are greater in individuals with lower insulin sensitivity, indicating a correlation with insulin resistance and secretion.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Meeting Abstract Endocrinology & Metabolism

Role of insulin signaling in the brain metabolism

Joao Duarte, Fernanda De Felice, Eugenio Barone, Elizabeth Rhea

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

Meeting Abstract Biochemistry & Molecular Biology

Insulin Signaling Regulates Mitochondrial Bioenergetics in the Brain: Insight for the Development of Neurodegenerative Diseases

Eugenio Barone

FREE RADICAL BIOLOGY AND MEDICINE (2022)

No Data Available